Covered recipient · General Payments record
SHIVAM G PATEL
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2024
$935.69
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.32 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $79.99 | 3 |
| Tandem Diabetes Care, Inc. | $45.45 | 2 |
| Insulet Corporation | $38.65 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $30.68 | 1 |
| Xeris Pharmaceuticals, Inc. | $22.76 | 1 |
| DEXCOM, INC. | $21.36 | 1 |
| Abbott Laboratories | $19.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.43 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124952822 | CMS |
| Dexcom, Inc. | $21.36 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153336489 | CMS |
| Insulet Corporation | $20.44 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804094 | CMS |
| Insulet Corporation | $18.21 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116811411 | CMS |
| Novo Nordisk Inc | $23.48 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096751967 | CMS |
| Novo Nordisk Inc | $29.57 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096654577 | CMS |
| Novo Nordisk Inc | $26.94 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097377724 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $30.68 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139165534 | CMS |
| Tandem Diabetes Care, Inc. | $18.97 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138743179 | CMS |
| Tandem Diabetes Care, Inc. | $26.48 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138748983 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.76 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144613646 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.